Hasil Pencarian - Nawid Albinger

  • Menampilkan 1 - 5 hasil dari 5
Perbaiki Hasil
  1. 1
    Immunotherapy with NK cells: recent developments in gene modification open up new avenues

    Immunotherapy with NK cells: recent developments in gene modification open up new avenues oleh Lisa Marie Reindl, Nawid Albinger, Tobias Bexte, Stephan Müller, Jessica Hartmann, Evelyn Ullrich

    Diterbitkan 2020-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia

    Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia oleh Nawid Albinger, Rita Pfeifer, Marcus Nitsche, Sarah Mertlitz, Julia Campe, Katja Stein, Hermann Kreyenberg, Ralf Schubert, Melissa Quadflieg, Dina Schneider, Michael W. M. Kühn, Olaf Penack, Congcong Zhang, Nina Möker, Evelyn Ullrich

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Immune profiling and functional analysis of NK and T cells in ataxia telangiectasia

    Immune profiling and functional analysis of NK and T cells in ataxia telangiectasia oleh Lea Graafen, Lea Graafen, Annekathrin Heinze, Annekathrin Heinze, Nawid Albinger, Nawid Albinger, Emilia Salzmann-Manrique, Franziska Ganß, Franziska Ganß, Franziska Ganß, Sabine Hünecke, Claudia Cappel, Sandra Wölke, Sandra Wölke, Helena Donath, Helena Donath, Jordis Trischler, Jordis Trischler, Till-Martin Theilen, Christine Heller, Christoph Königs, Stephan Ehl, Peter Bader, Thomas Klingebiel, Jan-Henning Klusmann, Jan-Henning Klusmann, Stefan Zielen, Stefan Zielen, Ralf Schubert, Ralf Schubert, Evelyn Ullrich, Evelyn Ullrich, Evelyn Ullrich, Evelyn Ullrich

    Diterbitkan 2024-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    P1354: CRISPR/CAS9 GENE EDITING OF IMMUNE CHECKPOINT RECEPTOR NKG2A IMPROVES THE ANTI-LEUKEMIC EFFICACY OF PRIMARY CD33-TARGETING CAR-NK CELLS.

    P1354: CRISPR/CAS9 GENE EDITING OF IMMUNE CHECKPOINT RECEPTOR NKG2A IMPROVES THE ANTI-LEUKEMIC EFFICACY OF PRIMARY CD33-TARGETING CAR-NK CELLS. oleh Nawid Albinger, Tobias Bexte, Ahmad Al-Ajami, Philipp Wendel, Leon Buchinger, Alec Gessner, Jamal Alzubi, Vinzenz Särchen, Meike Vogler, Raj Bhayadia, Jan-Henning Klusmann, Nina Möker, Toni Cathomen, Michael A. Rieger, Katharina Imkeller, Evelyn Ullrich

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells

    CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells oleh Tobias Bexte, Nawid Albinger, Ahmad Al Ajami, Philipp Wendel, Leon Buchinger, Alec Gessner, Jamal Alzubi, Vinzenz Särchen, Meike Vogler, Hadeer Mohamed Rasheed, Beate Anahita Jung, Sebastian Wolf, Raj Bhayadia, Thomas Oellerich, Jan-Henning Klusmann, Olaf Penack, Nina Möker, Toni Cathomen, Michael A. Rieger, Katharina Imkeller, Evelyn Ullrich

    Diterbitkan 2024-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: